Cloudflare, Inc. (N2ET34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 97.75 |
|---|---|
| 52-week range | 45.00 – 105.23 |
| Return, 1 month / 3 months | −2.9% / +29.1% |
| Return, 1 year / 3 years | +48.1% / +539.7% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 65.8% |
| Worst drawdown (1 year) | -39.2% |
| Average daily value traded | 3.99M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cloudflare is an internet infrastructure company based in San Francisco. It provides security, performance and reliability services that help websites and online applications run safely and quickly. Its offerings include protection against online attacks, content delivery, domain name services and tools that connect and secure corporate networks. Customers range from individual website owners to large organisations and enterprises around the world who rely on the company to keep their internet-facing services available and protected.
Cloudflare, Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code N2ET34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cloudflare, Inc. (N2ET34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 97.75 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 150 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 48.1% and over the last three months it rose 29.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 39.6% | ||
| From 52-week high | -6.0% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 29.1% | ||
| 6-month return | 66.3% | ||
| 12-month return, skipping the last month | 52.5% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 65.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.2% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 3.99M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +19.4% |
|---|---|
| 1 month | −2.9% |
| 3 months | +29.1% |
| 6 months | +66.3% |
| 1 year | +48.1% |
| 3 years | +539.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 91.05 / 70.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.99 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.